The Drawbacks of Your Product
Dr. Jordan Sudberg suggests that the single fundamental drawback of the product is that it is not a stand-alone product that can be purchased. Instead, the product must be used in conjunction with other products to work correctly.
To increase the limited number of products available, there is a risk that they may need to meet the required demand and, as such, require R&D or outsourcing for improvement. It may also mean producing more units or changing production processes to meet demand. Unlike many new technologies, which are developed on a small scale and then ramped up when proven successful, this product’s introduction will happen at full scale from day one, making these things much more complex than usual.
Furthermore, to increase the shelf-life and effectiveness of the product, the product will require a unique method of producing the main ingredients in mass quantities. There is no current technology that allows for the rapid production of these ingredients.
The first step to overcoming a drawback is ensuring it is a drawback. The most important thing that must happen before addressing the weaknesses of this product is to be sure that we are correct in our fundamental supposition and premise of the product. If we are right, it makes more sense to adjust our assumptions than to throw out the idea altogether. That said, if we are not accurate (or if there is any significant doubt), it is necessary to discard or change the picture entirely to save time and money on development.
Even if the product Idea itself is incorrect, it may still be possible to turn it into something that is an improvement over what we have now. Instead of a single product, multiple products can help address the same problem or handle various issues if packaged and distributed differently. It could be done by repackaging the Product for distribution on a smaller scale or adding additional products with complimentary ingredients and selling them as one package. This way, you could maintain reasonable control over production while making reaching the desired market demographic easier.
Another potential solution would be to distribute the product as pharmaceutical companies do. Suppose a pharmaceutical company wanted to have a new effect on the market. In that case, they might contract with a smaller company that would make the product to their specifications, but the pharmaceutical company would take care of marketing and distribution. This model could allow for faster production, distribution, and lower costs while maintaining quality control over the ingredients. A similar model could be used by keeping some of our components in-house while outsourcing others.
Dr. Jordan Sudberg concludes that the product is not currently feasible because it needs the ability to be used independently of others. It cannot also increase effectiveness, shelf-life, and production quickly. The possibility of solving these problems exists but requires significant resources that may be spent on research or outsourcing that could offer nothing more than a marginal improvement. It is recommended to discard this idea as a viable option in favor of another.